Bijay Baburajan

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

Nicholas A. Kennedy, Graham Heap, Harry Green et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 677 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease

Aleksejs Sazonovs, Nicholas A. Kennedy, Loukas Moutsianas et al. · Gastroenterology · 2019 · 409 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study

Neil Chanchlani, Simeng Lin, Claire Bewshea et al. · ˜The œLancet. Gastroenterology & hepatology · 2024 · 123 citations · Full text

Medicine, Clinical Sciences, Immunology +17

Long‐term outcome of using allopurinol co‐therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease

Azhar Ansari, Tim Elliott, Bijay Baburajan et al. · Alimentary Pharmacology & Therapeutics · 2008 · 117 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResource

Christina Kapizioni, R Desoki, Danielle Lam et al. · Journal of Crohn s and Colitis · 2023 · 110 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17